Hong Kong stock market anomaly | MedDoo Technology (02158.HK) rose more than 5%, winning the bid for the Phase III clinical research project of SMR001 eye drops.

Chinatimes Finance APP learned that Medisun Technology (02158.HK) rose by more than 5%, up 5.39% as of press time, with a price of 6.06 Hong Kong dollars and a turnover of 74.9734 million Hong Kong dollars.